Department of Clinical Neuroscience, Karolinska Institutet, St Erik Eye Hospital, Stockholm, Sweden.
Ophthalmology. 2010 Feb;117(2):381-7. doi: 10.1016/j.ophtha.2009.07.020. Epub 2009 Dec 14.
To compare spectacles plus patching >or=8 hours daily 6 days a week with spectacles plus patching >or=8 hours on alternate days to treat amblyopia in children 4 to 5 years of age.
Prospective, randomized clinical trial.
Forty children (median age, 4.3 years) with untreated amblyopia and a median best-corrected visual acuity (BCVA) in the amblyopic eye of 0.9 (range, 0.3-1.5) logarithm of the minimum angle of resolution.
Refractive correction was provided, and the children were randomized to patching >or=8 hours daily 6 days a week or patching >or=8 hours on alternate days. The BCVA, binocular function, and refractive errors were measured repeatedly during the study.
Median change in BCVA of the amblyopic eye after 1 year.
The median change in BCVA of the amblyopic eye did not differ significantly between the 2 groups (0.6 log units for daily occlusion; 0.8 log unit for alternate-day occlusion). The final median BCVA in the amblyopic eyes was 0.1 logarithm of the minimum angle of resolution in both groups. Binocular function improved in both groups with no significant differences between the groups at 1 year. The median spherical equivalent refractive error did not change significantly during the study period in the amblyopic eyes in either group; however, a significant increase was found in the fellow eyes in both groups (daily occlusion, P<0.05; alternate-day occlusion, P<0.001).
The magnitude of change in the BCVA 1 year after spectacles plus prescribed alternate-day patching was not significantly different than that after spectacles plus prescribed daily patching to treat amblyopia in children 4 to 5 years old. The effect of patching was not separate from that of optical correction with a period of refractive adaptation. Thus, the improvement in visual acuity is a combined effect of spectacle wear and occlusion therapy.
比较 4 至 5 岁儿童弱视治疗中每日戴镜加遮盖 8 小时且 6 天为一疗程与每日戴镜加遮盖 8 小时且隔天为一疗程的疗效。
前瞻性随机临床试验。
40 名(年龄中位数为 4.3 岁)未经治疗的弱视儿童,其最佳矫正视力(BCVA)在弱视眼中中位数为 0.9(范围,0.3-1.5)logMAR。
提供屈光矫正,将儿童随机分为每日戴镜加遮盖 8 小时且 6 天为一疗程组或每日戴镜加遮盖 8 小时且隔天为一疗程组。在研究期间,反复测量 BCVA、双眼功能和屈光不正。
1 年后弱视眼 BCVA 的中位数变化。
两组间弱视眼 BCVA 的中位数变化无显著差异(每日遮盖组为 0.6 log 单位;隔天遮盖组为 0.8 log 单位)。两组最终弱视眼的 BCVA 中位数均为 0.1 logMAR。两组的双眼功能在 1 年均有改善,两组间无显著差异。研究期间,两组弱视眼的平均等效球镜屈光度无显著变化;但两组对侧眼的屈光度均显著增加(每日遮盖组,P<0.05;隔天遮盖组,P<0.001)。
与每日戴镜加遮盖相比,4 至 5 岁儿童弱视治疗中隔日戴镜加遮盖 1 年后 BCVA 的变化幅度无显著差异。遮盖的效果不能与光学矫正的屈光适应期分开。因此,视力的提高是眼镜佩戴和遮盖疗法的综合效果。